Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 26;11(8):e0161686.
doi: 10.1371/journal.pone.0161686. eCollection 2016.

Serum 25-Hydroxyvitamin D3 and Mammography Density among Mexican Women

Affiliations

Serum 25-Hydroxyvitamin D3 and Mammography Density among Mexican Women

Amina Amadou et al. PLoS One. .

Abstract

Low circulating levels of vitamin D and high mammographic density (MD) have been associated with higher risk of breast cancer. Although some evidence suggested an inverse association between circulating vitamin D and MD, no studies have investigated this association among Mexican women. We examined whether serum 25-hydroxyvitamin D3 [25(OH)D3] levels were associated with MD in a cross-sectional study nested within the large Mexican Teacher's Cohort. This study included 491 premenopausal women with a mean age of 42.9 years. Serum 25(OH)D3 levels were measured by liquid chromatography/tandem mass spectrometry. Linear regression and non-linear adjusted models were used to estimate the association of MD with serum 25(OH)D3. Median serum 25(OH)D3 level was 27.3 (23.3-32.8) (ng/ml). Forty one (8%) women had 25(OH)D3 levels in the deficient range (< 20 ng/ml). Body mass index (BMI) and total physical activity were significantly correlated with 25(OH)D3 (r = -0.109, P = 0.019 and r = 0.095, P = 0.003, respectively). In the multivariable linear regression, no significant association was observed between 25(OH)D3 levels and MD overall. However, in stratified analyses, higher serum 25(OH)D3 levels (≥27.3 ng/ml) were significantly inversely associated with percent MD among women with BMI below the median (β = -0.52, P = 0.047). Although no significant association was observed between serum 25(OH)D3 and percent MD in the overall population, specific subgroups of women may benefit from higher serum 25(OH)D3 levels.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Association of serum 25(OH)D3 and percent MD, stratified by BMI.
Based on population distribution, the quartiles (25th percentile, 50th percentile, 75th percentile) of percent MD that divide the MD set into four equal group were estimated (MD ≤ 22.6%, 22.6–37.7%,; 37.5–51.9%, and > 51.9%). A subset of women was selected based on whether they had low percent MD (≤ 22.6%) or high percent MD (> 51.9%), and 25(OH)D3 concentrations were compared by multivariable logistic regressions. Multivariable models were adjusted for age, age at menarche, total physical activity and season of blood draw. Median BMI = 27.4 kg/m2, median serum 25(OH)D = 27.3ng/ml. N (high/low): number (high MD/ low MD), OR: odds ratio; 95% CI 95% confidence interval.
Fig 2
Fig 2. Fractional polynomial modelling of the association of serum 25(OH)D3 (ng/ml) with percent mammography density (MD).
A model with 95%CI among women with: A) BMI < median (< 27.4 kgm2), B) BMI ≥ median (≥ 27.4 kgm2).

Similar articles

Cited by

References

    1. Assi V, Warwick J, Cuzick J, Duffy SW (2012) Clinical and epidemiological issues in mammographic density. Nat Rev Clin Oncol 9: 33–40 - PubMed
    1. Huo CW, Chew GL, Britt KL, Ingman WV, Henderson MA, Hopper JL, et al. (2014) Mammographic density-a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat 144: 479–502 10.1007/s10549-014-2901-2 - DOI - PubMed
    1. White J (2000) Breast density and cancer risk: what is the relationship? J Natl Cancer Inst 92: 443 - PubMed
    1. Boyd NF, Martin LJ, Rommens JM, Paterson AD, Minkin S, Yaffe MJ, et al. (2009) Mammographic density: a heritable risk factor for breast cancer. Methods Mol Biol 472: 343–360 10.1007/978-1-60327-492-0_15 - DOI - PubMed
    1. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6: 798–808 - PubMed

LinkOut - more resources